Bayer Q3 Results - Q3 Top Pharma Company Earnings Reports
View Bayer's Q3 Earnings Report
Highlights:
- Bayer HealthCare posted another strong performance in the third quarter, with earnings up by a double-digit percentage.
- Sales of the subgroup rose by 3.5 percent (Fx & portfolio adj. 4.2 percent) to EUR 3,936 million (Q3 2008: EUR 3,802 million).
- The Pharmaceuticals segment raised sales by 3.0 percent (Fx & portfolio adj. 3.8 percent) to EUR 2,548 million, performing especially well in Asia and Latin America
Check out Pfizer's current earnings estimates from CNN Money
Bayer's Website: http://www.bayer.com/
Related Articles:
Bayer sued over prostate cancer claim
FDA issues warning letter over Yaz DTC ads
New safety probe for Bayer contraceptive
Who's the greenest pharma of all?
Bayer, FDA debate GMPs at German plant
More stories about Bayer
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: